Related Experiment Video

Updated: Aug 26, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.0K

Respiratory Syncytial Virus

Leah Khan

    Pediatric Annals
    |October 10, 2022
    PubMed

    Insights

    Respiratory syncytial virus (RSV) infects most children, causing mild to severe illness. Research focuses on protecting at-risk populations and developing new vaccines and treatments for this challenging virus.

    Area of Science:

    • Pediatrics
    • Virology
    • Infectious Diseases

    Background:

    • Respiratory syncytial virus (RSV) is a common virus affecting nearly all children by age two.
    • RSV infection presents a spectrum of illness, from mild colds to life-threatening respiratory failure.
    • Pediatricians frequently encounter RSV, necessitating awareness of at-risk groups and management strategies.

    Purpose of the Study:

    • To highlight populations at risk for severe respiratory syncytial virus (RSV) disease.
    • To discuss current and future strategies for RSV prevention and treatment.
    • To underscore the ongoing challenges in controlling RSV despite its ubiquity.

    Main Methods:

    • Literature review of existing studies on RSV epidemiology and clinical management.
    • Analysis of current preventive measures and treatment options for RSV.
    • Exploration of emerging technologies and research directions for RSV control.

    Main Results:

    • RSV poses a significant health burden, particularly for vulnerable populations.
    • Existing preventive measures for RSV are limited in efficacy and duration.
    • RSV remains a challenging virus to control, with ongoing research into novel interventions.

    Conclusions:

    • Effective prevention and treatment of RSV require a comprehensive approach targeting at-risk individuals.
    • Advancements in vaccine technology and immunoprophylaxis offer future hope for RSV control.
    • Continued research is crucial for developing better therapeutic options and long-term protection against RSV.

    More Related Videos

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.0K
    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 10, 2013

    8.0K

    Related Concept Videos

    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
    5.3K
    Common Respiratory Disorders01:31

    Common Respiratory Disorders

    Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
    Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
    822
    Pulmonary Cycle: Exhalation01:17

    Pulmonary Cycle: Exhalation

    In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
    1.7K
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...
    185
    Acute Respiratory Failure-I01:21

    Acute Respiratory Failure-I

    Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
    Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
    287
    Acute Respiratory Failure-II01:21

    Acute Respiratory Failure-II

    Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
    The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
    320